SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Catalyst CEL Management Ltd., et al. – ‘SC 13G’ on 12/29/17 re: Eloxx Pharmaceuticals, Inc. – ‘EX-2’

On:  Friday, 12/29/17, at 5:25pm ET   ·   Accession #:  1144204-17-65936   ·   File #:  5-56243

Previous ‘SC 13G’:  None   ·   Next:  ‘SC 13G/A’ on 2/6/19   ·   Latest:  ‘SC 13G/A’ on 4/29/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/29/17  Catalyst CEL Management Ltd.      SC 13G                 6:141K Eloxx Pharmaceuticals, Inc.       Toppan Vintage/FA
          Catalyst Cel Fund L.P.
          Cel Catalyst China Israel Fund L.P.
          Cel Catalyst China Israel General Partner Ltd

Statement of Beneficial Ownership   —   Sch. 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Beneficial Ownership                   HTML     45K 
 2: EX-1        Underwriting Agreement                              HTML      9K 
 3: EX-2        Plan of Acquisition, Reorganization, Arrangement,   HTML     11K 
                          Liquidation or Succession                              
 4: EX-3        Articles of Incorporation/Organization or By-Laws   HTML     11K 
 5: EX-4        Instrument Defining the Rights of Security Holders  HTML     11K 
 6: EX-5        Opinion re: Legality                                HTML     11K 


EX-2   —   Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 2

 

LIMITED POWER OF ATTORNEY

 

The undersigned hereby constitutes and appoints Gregory Weaver with full power of substitution, as the undersigned’s true and lawful attorney-in-fact to:

 

(1)prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC;

 

(2)execute for and on behalf of the undersigned, in the undersigned’s capacity as officer and/or director of Eloxx Pharmaceuticals, Inc. (the “Company”), Forms 3, 4, 5 and any Schedules 13D or 13G in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;

 

(3)do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or Schedule 13D or 13G, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and

 

(4)take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5, and any Schedules 13D or 13G with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

 

[Remainder of page intentionally left blank]

 

 

 

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of December, 2017.

 

  Catalyst CEL Management Ltd.
   
  By: /s/ Yair Shamir
  Name: Yair Shamir
  Title: Managing Partner

 

[Signature Page to Limited Power of Attorney]

 

 

Top
Filing Submission 0001144204-17-065936   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 10:13:04.1am ET